WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2013113755) REAGENTS AND METHODS FOR THE TREATMENT OF DISEASES BASED ON THE INHIBITION OF CALCINEURIN - NFAT SIGNALLING PATHWAY
Latest bibliographic data on file with the International Bureau   

Pub. No.: WO/2013/113755 International Application No.: PCT/EP2013/051798
Publication Date: 08.08.2013 International Filing Date: 30.01.2013
IPC:
C07K 14/47 (2006.01) ,A61K 38/17 (2006.01) ,G01N 33/68 (2006.01)
Applicants: FUNDACIÓ INSTITUT D'INVESTIGACIÓ BIOMÈDICA DE BELLVITGE (IDIBELL)[ES/ES]; Hospital Duran i Reynals 3ª planta Gran Via de l´Hospitalet, 199 E-08908 Hospitalet de Llobregat, ES
LYKERA BIOMED S.A.[ES/ES]; Calle de la Innovació, 2 E-08225 Terrasa, ES
UNIVERSITAT AUTÒNOMA DE BARCELONA[ES/ES]; Edifici A - Campus Universitari s/n E-08193 Bellaterra, ES
Inventors: PÉREZ-RIBA, Mercè; ES
MARTÍNEZ HØYER, Sergio; ES
MESSEGUER PEYPOCH, Ramon; ES
ITARTE FRESQUET, Emilio; ES
Agent: ALCONADA RODRÍGUEZ, Agustín; ABG Patentes, S.L. Avenida de Burgos, 16D Edificio Euromor E-28036 Madrid, ES
Priority Data:
12382035.930.01.2012EP
Title (EN) REAGENTS AND METHODS FOR THE TREATMENT OF DISEASES BASED ON THE INHIBITION OF CALCINEURIN - NFAT SIGNALLING PATHWAY
(FR) RÉACTIFS ET MÉTHODES UTILISABLES EN VUE DU TRAITEMENT DE MALADIES PAR INHIBITION DE LA VOIE DE SIGNALISATION CALCINEURINE-NFAT
Abstract: front page image
(EN) The present invention relates to peptides derived from the RCAN proteins for their use in medicine and in the treatment of diseases in a subject occurring with uncontrolled cell proliferation, immune disorders, cardiovascular disorders, neurodegenerative diseases, alopecia, undesired angiogenesis and undesired PMN infiltration.
(FR) La présente invention concerne des peptides dérivés des protéines RCAN pouvant être utilisés en médecine et dans le cadre du traitement de maladies chez un sujet souffrant d'une prolifération cellulaire incontrôlée, d'un déficit immunitaire, d'une affection cardiovasculaire, d'une maladie neurodégénérative, d'une alopécie, d'une angiogenèse indésirable ou d'une infiltration leucocytaire indésirable par des polynucléaires neutrophiles.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW
African Regional Intellectual Property Organization (ARIPO) (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Office (AM, AZ, BY, KG, KZ, RU, TJ, TM)
European Patent Office (EPO) (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG)
Publication Language: English (EN)
Filing Language: English (EN)